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Abstract 
In a large series of nonselected autopsy investigations an accessory spleen was found in 
10–30%. The second most common site is the pancreatic tail (17%). We report a case of 
intrapancreatic accessory spleen misdiagnosed as a nonsecreting neuroendocrine tumor 
of the pancreas. Nuclear scintigraphy may provide the definitive diagnosis of an 
intrapancreatic spleen and therefore prevent patients from unnecessary major surgery. 
Introduction 
An intrapancreatic accessory spleen may be misdiagnosed as a nonsecreting 
neuroendocrine tumor of the pancreas. An accurate diagnosis is crucial since such an 
accessory spleen does not require surgical treatment. We report a case of an 
intrapancreatic accessory spleen with review of the literature. 
Case Report 
A 67-year-old woman in good general conditions with a family history positive for pancreatic cancer 
underwent a routine health check. Her personal history was completely uneventful without any 
symptoms present. Physical examination was normal and laboratory tests revealed normal alpha 
fetoprotein and carcinoembryonic antigen but a slightly elevated tumor marker CA 19-9 (35 U/ml; 
normal <27.0 U/ml). Additional laboratory tests such as chromogranin A, neuron-specific enolase, 
5-hydroxyindoleacetic acid, pancreatic polypeptide and substance P were ordered and normal beside a 
slightly elevated pancreatic polypeptide level (437 pg/ml; normal <210 pg/ml). The patient also  
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underwent a CT scan investigation which showed a 18 × 15 × 15 mm nodular lesion in the tail of the 
pancreas without any contrast enhancement (fig. 1). An additional octreotide scan was normal. Because 
of the abnormal tumor markers CA 19-9 and pancreatic polypeptide, a neuroendocrine tumor was 
suspected, although the image appearances were not typical. Due to this potentially malignant lesion the 
patient underwent a left-sided splenopancreatectomy. Intraoperatively, a dark red but soft tumor was 
found in the tail of the pancreas and the lesion was also confirmed by intraoperative sonography. 
Postoperative histopathological examination revealed a completely intrapancreatic accessory spleen 
without any signs of a tumor (fig. 2, fig. 3). The patient’s postoperative recovery was uneventful.  
Discussion 
During the 5th week of gestation the spleen develops in the dorsal mesogastrium from 
mesenchymal cells that migrate between the leaves of the mesentery and coalesce [1]. An 
accessory spleen may arise from isolated cells which rest separated from the main body of 
the spleen. In a large series of nonselected autopsy investigations an accessory spleen was 
found in 10–30% [1, 2]. In 1,000 consecutive patients undergoing contrast-enhanced 
abdominal CT scan an accessory spleen was present in 16% [3]. In 80% the accessory 
spleen is located at or near the splenic hilum. The second most common site is the 
pancreatic tail (17%) [2].  
Differential diagnosis of a solid pancreas tumor includes pancreatic adenocarcinoma, 
pancreatic neuroendocrine tumor, solid and papillary epithelial neoplasms and 
metastasis. Pancreatic endocrine tumors are rare (<10%) and often localized in the head 
of the pancreas [4, 5]. Due to secretion of biologically active substances, 15–53% of these 
tumors become symptomatic [4], all others remain initially silent. However 50% of these 
nonsecreting endocrine tumors are malignant and require surgical resection [6].  
In the English language literature only 11 cases of surgical resection of an 
intrapancreatic accessory spleen have been reported up to now [7]. In most of these cases 
the intrapancreatic accessory spleen was misdiagnosed as a pancreatic tumor and patients 
underwent unnecessary surgery. Most intrapancreatic accessory spleens are roundish and 
have a characteristic homogenous contrast-enhanced appearance on CT scan with 
well-defined margins. Most often they are small with a diameter of less than 2 cm [8]. 
However, definitive diagnosis based on imaging can be difficult because CT scan, MRI 
and ultrasound images of such intrapancreatic spleens are quite similar to those of 
hypervascular pancreatic tumors, as islet cell tumors and acinar cell carcinoma [9]. 
Using contrast-enhanced ultrasound, Ota and Ono [9] demonstrated in the 
hepatosplenic phase that contrast medium is trapped by hepatic and splenic tissue, which 
may allow to distinguish an intrapancreatic spleen from other lesions. Somatostatin 
receptor scintigraphy (octreotide scan) has a high sensitivity in detection of 
gastrointestinal neuroendocrine tumors (70–95%) [10]. However, octreotide scan may 
also give false-positive results. The presence of somatostatin receptors on the surface of 
lymphocytes within the splenic tissue, which also bind octreotide with a high affinity, may 
therefore mimic a neuroendocrine tumor [10, 11]. Heredia et al. [12] diagnosed in three 
of five patients an intrapancreatic accessory spleen based on the findings of standard 
gadolinium-enhanced MRI. However, they were not able to exclude other diagnoses with 
this investigation, including pancreatic neuroendocrine tumors, pancreatic 
adenocarcinomas, solid and papillary epithelial neoplasms, and metastasis. 
The only possibility to differentiate an accessory spleen from a neuroendocrine tumor 
are nuclear scintigraphic investigations as 99m Tc-sulphur colloid or Tc-tagged  
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heat-damaged red blood cells scintigraphies. These are investigations which are 
noninvasive, sensitive and specific for detecting splenic tissue [13, 14]. 
Conclusion 
In asymptomatic homogenous and well-circumscribed tumors in the pancreatic tail an 
accessory spleen has to be excluded before surgery. Nuclear scintigraphies such as 99m 
Tc-sulphur colloid or Tc-tagged heat-damaged red blood cells scintigraphies should be 
definitely routinely used in the preoperative evaluation of nonsecreting pancreatic lesions, 
particularly those which are located in the body and tail of the pancreas. These imaging 
modalities may provide the definitive diagnosis of an intrapancreatic spleen and therefore 
prevent patients from undergoing unnecessary major surgery. 
 
 
 
 
 
Fig. 1. Arterial phase contrast-enhanced CT scan. Intrapancreatic tumor (arrow) without any contrast 
enhancement. 
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Fig. 2. Resected pancreatic tail with the aspect of a well-defined round tumor. 
 
 
 
Fig. 3. Histologic staining confirming an intrapancreatic spleen (S) surrounded by pancreatic tissue 
(P). Hematoxylin-eosin staining. 
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